Skip to content
Clinical Trials – home
Verifiedinfo

Research Center for Medical Studies (RCMS)

Germany Hohenzollerndamm 2, 10717 Berlin, Germany

  • 4 trials recruiting
  • Asthma · Chronic obstructive pulmonary disease · Asthmatic crisis
  • Adults and children

About Specializations

Research Center for Medical Studies (RCMS) in Berlin, Germany specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Asthmatic crisis, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The Research Center for Medical Studies in Berlin focuses on advancing treatments for respiratory conditions. It targets asthma and aims to lower the frequency of severe attacks. It also addresses chronic obstructive pulmonary disease to improve long‑term lung function.

  • Evaluation of novel anti‑inflammatory agents as add‑on therapy
  • Assessment of exacerbation rates with emerging biologics

These studies test new medications alongside standard inhaled corticosteroid/long‑acting β2‑agonist regimens to enhance disease control and safety for patients with persistent respiratory symptoms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hohenzollerndamm 210717 BerlinGermany
Recruiting now
4 trials
Conditions studied
3
Partner status
Verified

More sites in BerlinGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

20 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.